Wird geladen...
1ISG-020 Market access in the eu, do we have enough evidence?
BACKGROUND: The European Medicines Agency (EMA) is responsible for the scientific evaluation of medicines for use in the European Union (EU), providing a scientific opinion on the granting of EU-wide marketing authorisations. PURPOSE: We conducted a retrospective analysis of new active substances (N...
Gespeichert in:
| Veröffentlicht in: | Eur J Hosp Pharm |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Group
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535274/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.20 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|